"10.1371_journal.pone.0101522","plos one","2014-07-11T00:00:00Z","Ruan Kruger; Lars M Rasmussen; William S Argraves; Jesper Eugen-Olsen; Olav W Nielsen; Adam Blyme; Ronnie Willenheimer; Kristian Wachtell; Michael H Olsen","Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa; The Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark; Department of Clinical Biochemistry and Pharmacology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark; Medical University of South Carolina, Department of Cell Biology, Charleston, South Carolina, United States of America; Clinical Research Centre 136, Hvidovre Hospital, Copenhagen, Denmark; Department of Cardiology, Bispebjerg Hospital, Copenhagen, Denmark; Department of Cardiology, Glostrup Hospital, Copenhagen, Denmark; Lund University and Heart Health Group, Malm√∂, Sweden; Department of Medicine, Glostrup Hospital, Copenhagen, Denmark","Conceived and designed the experiments: MHO KW LMR JE OWN. Performed the experiments: RK MHO. Analyzed the data: RK MHO. Contributed reagents/materials/analysis tools: LMR JE KW WSA OWN. Wrote the paper: RK MHO LMR WSA JE KW AB RW OWN.","Roche Diagnostics have performed the NT-proBNP measurements for this study, without requiring any restrictions for the investigators. Roche Diagnostics was completely blinded for the clinical data and had no influence on the hypotheses, data collection and analyses, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","07","Ruan Kruger","RK",9,TRUE,5,2,2,9,TRUE,TRUE,FALSE,0,NA,FALSE
